Industry News
FDA Prohibits Another Ranbaxy Facility from Producing Drugs for US Market
FDA adds Ranbaxy's Toansa, India facility to existing consent decree, prohibiting distribution of APIs from that location
EMA Recommended 81 Medicines for Marketing Authorization in 2013
In 2013, the EMA's Committee for Medicinal Products for Human Use recommended 81 medicines for human use for marketing authorization, compared with 57 in 2012.
Stevens Institute of Technology Opens Biotechnology and Drug–Discovery Laboratory
The Stevens Institute of Technology will open a new biotechnology laboratory in January 2014.
Agilent Technologies, Picometrics Technologies to Offer CE–LIF–MS Systems
Combined technologies from Agilent Technologies and Picometrics Technologies are designed for large–molecule analysis.
Novasep Appoints New President of Synthesis Business Unit
Novasep selects Thierry van Nieuwenhove as new president of the synthesis business unit.
Lonza Signs Agreement with Index Ventures for Biological Products
Lonza signs an agreement with Index Ventures for the development and manufacture of biologics for portfolio companies.
USP Inaugurates Expanded Shanghai Facility
USP opens expanded Shanghai facility to enhance quality standards for medicines and food ingredients.
CBR–SYNARC and BioClinica Merge And Appoint New Chairman
CCBR–SYNARC and BioClinica merge to create a provider of specialized outsourced clinical services.
Merck Recalls Cholesterol Medicine Due to Packaging Defect
A packaging defect has led to Merck voluntarily recalling all lots of Liptruzet tablets in the United States.
CytomX Therapeutics and ImmunoGen to Develop Probody-Drug Conjugates
CytomX Therapeutics and ImmunoGen announce collaboration to develop probody-drug conjugate therapies for the treatment of cancer.
Eurofins Acquires the Discovery and Development Solutions Business of Merck KGaA
Eurofins acquires DDS business of Merck KGaA in order to expand discovery solutions and bioanalytical services.
LSNE Completes FDA Inspection
LSNE completes an FDA inspection of its Manchester manufacturing facility.Lyophilization Services of New England (LSNE),
Genzyme Receives Complete Response Letter from FDA on Lemtrada Application
Genzyme plans to appeal FDA?s decision that the multiple-sclerosis treatment is not ready for approval.
Baxter Initiates Worldwide Voluntary Recall
Baxter International recalls dextrose injection and four sodium chloride injections.
Pall Corporation to Acquire ATMI's LifeSciences Business for $185 million
Pall Corporation, a solutions provider in filtration, separation and purification, has signed a definitive agreement with ATMI to acquire ATMI's LifeSciences business unit for $185 million.
Merck and GlaxoSmithKline Collaborate on Pazopanib
Merck and GlaxoSmithKline begin clinical trial of pazopanib for the treatment of advanced renal-cell carcinoma.
Bind, Amgen Amend Pact
Bind Therapeutics amends its development and commercialization collaboration agreement with Amgen.
CMC Biologics and OncoSynergy Form Pact
CMC Biologics and OnoSynergy form an agreement from cell-line development.
Pfizer Appoints Head of Vaccines
Pfizer appoints management changes to take effect in 2014.
Pfenex Awarded Anthrax Inspection
Leidos Holdings awards Pfenex a subcontract in support of the development of an anthrax vaccine.
Pfizer, Siemens Partner in Companion Diagnostics
Siemens enters agreement with Pfizer to commercialize diagnostic tests for therapeutic products across Pfizer's pipeline.
ProBioGen, Emergent BioSolutions Partner in Vaccine Manufacturing
ProBioGen signs agreement with Emergent BioSolutions for access to ProBioGen's avian AGE1.CR cell line.
Nearly 400 Drugs in Development for Infectious Diseases
Almost 400 new medicines for infectious diseases, including viral infections, bacterial infections, fungal infections and parasitic infections.
J&J Innovation Announces Opening of Offices
Johnson&Johnson will open a network of partnering offices across the UK.
Lonza, BioWa Sign Licensing Agreement
BioWa and Lonza have entered into a licensing agreement with MedImmune for cell line technology.
Pfizer, Octopharm Partner
Octapharma and Pfizer form an agreement for the future marketing and commercialization of human prothrombin complex concentrate.
GSK Launches Cancer Research Consortium
GSK forms the Oncology Clinical and Translational Consortium, a scientific research network comprised of six international cancer centers.
BMS Names New Board Member
Bristol-Myers Squibb has elected Thomas Lynch, Jr., MD to its board of directors.
LSNE Appoints New COO
LSNE appoints Shawn Cain as COO, a new position within the company.
TxCell's Manufacturing Facility Approved for Cell-Therapy Production
TxCell has received manufacturing accreditation status of its cell-therapy production site in Besancon, France, from the French National Agency for Drug Safety (ANSM).
